Observational study reveals TGF-ß1 and CTGF mRNA link to urinary protein levels in IgAN, suggesting prognostic value.
The degree of tubulointerstitial fibrosis is a poor prognostic indicator in IgA nephropathy (IgAN). Recently, connective tissue growth factor (CTGF) was observed to be strongly up-regulated in human proliferative and fibrogenic diseases. Renal biopsy specimens were obtained from the 20 patients with IgAN. Based on a previously reported study (MDRD study), all cases were categorized into 2 groups. Group A included patientswith urinary protein (u-protein) <1.0 g/day, and group B, those with u-protein ≥1.0 g/day. Expressions of transforming growth factor ß1 (TGF-ß1) and CTGF mRNAs in tubular epithelial cells (TECs) were examined in all cases using rapid in situ hybridization (rISH). Significantly strong and diffuse expressions of TGF-ß1 and CTGF mRNAs were observed in proximal TECs in group B, while the expressions of these 2 mRNAs were weak in proximal TECs in group A and in glomerular resident cells in both groups. These results closely correlated with the degree of disorder in conventional pathohistological findings and clinical parameters except for u-protein level. The increase of u-protein level is one of the most important factors influencing the expression of TGF-ß1 and CTGF mRNAs in TECs. Therefore, the authors conclude that both u-protein level and expressions of these 2 mRNAs in TECs were significantly correlated with the degree of tubulointerstitial damage in IgAN.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: